WebJun 13, 2005 · Cisplatin is a platinum based chemotherapy agent used to treat various sarcomas, carcinomas, lymphomas, and germ cell tumors. Brand Names. Platinol. … WebOct 22, 2024 · Nephrotoxicity: Cisplatin, the main chemo drug used to treat cervical cancer, can damage the kidneys (also called nephrotoxicity). Many times the damage is preventable and reversible, but sometimes the damage may be long-lasting. Often, there are no symptoms, but the damage can be seen on bloodwork done routinely while chemo is …
Development and Validation of a Simple and Sensitive ... - Hindawi
WebBody Surface Area Based Dosing Medication dose adjustment based on body surface area (BSA) Questions 1.BSA Based Dose 2.Weight 3.Height 4.Select either 5.Desired dose unit About Body surface area... WebSep 3, 1991 · The use of infusional fluorouracil with concurrent conventionally fractionated radiation therapy and cisplatin infusion results in mucositis that limits the dose of fluorouracil to levels that are probably subtherapeutic. Publication types Research Support, Non-U.S. Gov't MeSH terms Adult how far from mainland china is taiwan
Cisplatin - NCI - National Cancer Institute
WebJan 8, 2024 · The actually utilized dose (AD) of cisplatin was calculated using the following formula: AD (mg) = total dose (TD) (mg)-losing dose (LD) (mg); LD = volume (ml) of the perfusate (VP retained) that was retained in the HIPEC treatment system at the end of HIPEC * concentration of cisplatin in the perfusate (mg/ml). WebFeb 16, 2016 · However a recent systematic review assessing optimal cisplatin dosage suggests a cumulative dose of at least 200 mg/m 2 cisplatin . As we speculate that dose reduction leads to decreased loco-regional survival, more kidney damage therefore seems acceptable but it is more important to minimize the toxic side effects of cisplatin. … WebMay 11, 2012 · Cisplatin is a prescription medicine used alone to treat bladder and ovarian cancer . Cisplatin is also used together with other drugs to treat: testicular cancer locally advanced squamous cell carcinoma of the head and neck late stage cervical cancer malignant mesothelioma non-small cell lung cancer that can not be treated with surgery hierarchy settings sccm